The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Open accessAbstract
Natural killer (NK) cells are a population of innate lymphoid cells playing a pivotal role in host immune responses against infection and tumor growth. These cells have a powerful cytotoxic activity orchestrated by an intricate network of inhibitory and activating signals. The importance of NK cells in controlling tumor growth and in mediating a robust anti-metastatic effect has been demonstrated in different experimental mouse cancer models. Consistently, high density of tumor-infiltrating NK cells has been linked with a good prognosis in multiple human solid tumors. However, there are also tumors that appear to be refractory to NK cell-mediated killing for the presence of an immunosuppressive microenvironment affecting NK cell function. Immunotherapeutic strategies aimed at restoring and increasing the cytotoxic activity of NK cells in solid tumors, including the adoptive transfer of NK and CAR-NK cells, are currently employed in preclinical and clinical studies. In this review, we outline recent advances supporting the direct role of NK cells in controlling expansion of solid tumors and their prognostic value in human cancers. We summarize the mechanisms adopted by cancer cells and the tumor microenvironment to affect NK cell function, and finally we evaluate current strategies to augment the antitumor function of NK cells for the treatment of solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–207 of 207
He, Y., Liu, S., Mattei, J., Bunn, P. A., Zhou, C., & Chan, D. C. F. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s163304 · Cited by 35
Li, D., Long, W., Huang, R., Chen, Y., & Xia, M. (2018) · Obesity · doi:10.1002/oby.22130 · Cited by 33
The kiss of death: interrupted by NK-cell close encounters of another kind
Wahl, S. M., Wen, J., & Moutsopoulos, N. M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.002 · Cited by 30
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
Carrega, P., & Ferlazzo, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00277 · Cited by 27
Canter, R. J., Ames, E., Mac, S., Grossenbacher, S. K., Chen, M., Li, C., Borys, D., Smith, R. C., Tellez, J., Sayers, T. J., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-756 · Cited by 25
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215950 · Cited by 23
Checkpoint inhibition: NK cells enter the scene
Stojanovic, A., & Cerwenka, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0142-y · Cited by 21
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Bald, T., Krummel, M. F., Smyth, M. J., & Barry, K. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0728-z · Cited by 506
A pan-cancer single-cell panorama of human natural killer cells
Tang, F., Li, J., Qi, L., Liu, D., Bo, Y., Qin, S., Miao, Y., Yu, K., Hou, W., Li, J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.034 · Cited by 450
“However, NK-cell-based therapies are hindered in solid tumors partly due to the incomplete understanding of tumor-infiltrating NK cells, especially their infiltration to tumor, phenotypic heterogeneities, and dysregulation within the TME.(7,8) In humans, NK cells can be subdivided into two major groups, CD56CD16 and C…”
BackgroundInfluentialChimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Gong, Y., Klein Wolterink, R. G. J., Wang, J., Bos, G. M. J., & Germeraad, W. T. V. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01083-5 · Cited by 379
Metadata
- Authors
- Melaiu, O., Lucarini, V., Cifaldi, L., & Fruci, D.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-01-21
- Volume
- 10
- Pages
- 3038-3038
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3001496296
- Cited by
- 419
- References
- 207
- FWCI
- 17.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.